LENZING AG |
Market Closed -
Other stock markets
|
After market 12:35:06 am | |||
| 34.9 EUR | +3.48% |
|
35.02 | +0.36% |
| 08/05 | Transcript : Lenzing Aktiengesellschaft, Q1 2024 Earnings Call, May 08, 2024 | |
| 03/05 | Lenzing Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -1.83% | 1.42B | - | ||
| +24.74% | 5.75B | C | ||
| -2.71% | 4.85B | C- | ||
| +4.21% | 3.74B | C | ||
| -4.76% | 2.05B | - | - | |
| +0.63% | 1.58B | B+ | ||
| -8.37% | 972M | - | D+ | |
| +1.12% | 996M | - | ||
| +1.47% | 632M | - | - | |
| -21.86% | 465M | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- LNZ Stock
- 0NCV Stock
- Ratings Lenzing AG